Previous id grand Rounds

Download 277.87 Kb.

Date	31.01.2017
Size	277.87 Kb.
	#12891

Previous ID Grand Rounds

2010

1/27/10	William Klingensmith, MD	Imaging Infection with FDG & PET-CT: The Best Imaging Study for Infection	Professor of Radiology, Director, Division of Nuclear Medicine, UC Denver
2/10/10	Robert Belknap, MD	INFgamma Release Assays for Diagnosis of TB	Assistant Professor, Division of Infectious Diseases - UC Denver
2/17/10	Alia Al-Tayyib, PhD	HIV Behavioral Surveillance Project	Assistant Research Scientist, Assistant Professor Epidemiology Department, Colorado School of Public Health
3/3/10	Kevin High, MD	HIV and Aging: Pathogenesis, Outcomes and Future Research Priorities	Professor of Medicine, Chief, Section of Infectious Diseases, Wake Forest University
3/10/10	Richard Haubrach, MD	Regimens for Treatment Experienced HIV-Infected Patients: Which Agents, How Many and Why (and How the Resistance Test Can Help)	Professor of Medicine, Division of Infectious Diseases, University of California, San Diego, CA
3/31/10	Carlos Del Rio, MD	Tim Gill Lecture Presentation: Sex, Drugs, and HIV: The Synergistic Epidemics of Crack Cocaine and HIV	Professor/Chair - Hubert Department of Global Health, Rollins School of Public Health. Professor of Medicine in Infectious Diseases at the Emory University School of Medicine
4/7/10	Ken Tyler, MD	West Nile Virus Neuroinvasive Disease	Reuler-Lewin Family Professor and Chair of Neurology. Professor of Medicine, Microbiology and Immunology UC Denver
5/5/10	Marinka Kartalija, MD	Characterizing Body Morphotype and Serum Adipokine & Cytokine Levels in Patients with Nontuberculosis Mycobacteruak (NTM) Lung Disease	Fellow, Infectious Diseases, UC Denver
5/12/10	Jing Kroll, MD	The use of EBV Lytic and Latency III mRNA and of Viral DNA for Early Detention of PTLD	Fellow, Infectious Diseases, UC Denver
6/2/10	Kristine Erlandson, MD		Fellow, Infectious Diseases, UC Denver
6/16/10	Margaret McLees, MD		Fellow, Infectious Diseases, UC Denver

2009

2/4/2009	Sam MaWhinney, PhD	Statistics 101	Professor, Preventive Medicine and Biostatistics – UC Denver
4/1/2009	Alicia Cronquist, RN, MPH	Trends in Shiga toxin-producing E. Coli (STEC) Infection	Foodborne/Enteric Disease Epidemiologist. CO Dept. of Public Health and Environment
5/6/2009	Beth Jamieson, PhD	The Dual Impact of HIV and Age on T-Cells; Why getting HIV makes you old	Associate Professor, Division of Hematology & Oncology, UCLA David Geffen School of Medicine
6/3/2009	Vivian Cox, MD	HIV-1 Infection of Follicular CD4+ Lymphocites	ID Fellow – UC Denver
8/12/2009	Mary Kestler, MD	TB/HIV Education and Care Program for Health Care Workers in Botswana	Head, TB/HIV Program, Botswana-University of Pennsylvania
8/19/2009	Joshua Christensen, MD	Metabolic Drug Targets in TB	ID Fellow, UC Denver
9/9/2009	Nina Singh, MD	Current Challenges and Evolving Concepts in the Management of Invasive Fungal Infections in Solid Organ Transplant Recipients	Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh
9/16/2009	Eric Kajioka, MD	Risk Factors of Clostridium Difficile Infection in Hospitalized Adults	ID Fellow, UC Denver
9/30/2009	Charles Steinberg, MD	AIDS in Africa, One Colorado Doctor’s Experience	Consultant and Trainer, ID Institute
11/11/2009	Dan Bausch, MD	Challenges to Diagnosis the Viral Hemorrhagic Fevers	Associate Professor, Department of Tropical Medicine, Tulane School of Public Health and Tropical Medicine

2008

Date	Speaker	Topic	Affiliation/Contact
1/10/2008	Theresa Pacheco, MD	HIV Lipoatrophy	Medical Director, Associate Professor, Department of Dermatology, UC Denver
1/17/2008	Ralph Wilmoth	The Current Increase in Syphillis	STD/HIV Section Chief, CDPHE
1/24/2008	Dennis Stevens, MD, PhD	Pathogenic Mechanisms and Antimicrobial Treatment of Toxin Related Infections Caused by Gram Positive Microbes	Professor of Medicine, University of Washington
1/31/2008	David Margolis, MD	Mechanisms that Maintain HIV Latency: Targets for Future Therapeutics to Eradicate Persistent Infection	Professor of Medicine, Microbiology and Immunology, Epidemiology, University Of North Carolina at Chapel Hill
2/14/2008	William Claude Klingensmith, MD	Imaging Infection with FDG & PET-CT	Director, Hewit Biomolecular Imaging Center, Porter Hospital
2/21/2008	Dan Kuritzes, MD	HIV-1 Entry, Chemokine Receptors, and CCR5 Antagonists	Professor of Medicine, Harvard Medical School
3/6/2008	Glenn Treisman, MD, PhD	HIV and Depression	Director of HIV Mental Health, Johns Hopkins
3/13/2008	Thomas Gootz, MD	Carbapenem-Resistance in Klebisiella Pneumoniae, a Global Problem	Department of Antibiotics, Immunology, and Cancer, Pfizer
3/20/2008	Hugo Rosen, MD	Hepatitis C	Professor of Medicine, Division Head of Gastroenterology, UC Denver
4/10/2008	Edward Gardner, MD	HIV and Medication Adherence	Assistant Professor of ID, UC Denver
4/17/2008	Rohini Sharma, MD	Staphylococcus and Epidural Abscesses	ID Fellow, UC Denver
5/1/2008	Rawleigh Howe, MD	Dendritic Cells and HIV	ID Fellow, UC Denver
5/15/2008	Minal Kapoor, MD	Central Blood Stream Infection Prevention	ID Fellow, UC Denver
5/22/2008	Daniel Musher, MD	Syphillis	Professor of Medicine, Baylor University
6/5/2008	Timothy Jenkins, MD	CA-MRSA USA300 Bloodstream Infections in Denver’s Health Care System	ID Fellow, UC Denver
6/12/2008	Carla Saveli, MD	The Role of Antibiotics in Open Fractures in the Era of CA-MRSA	ID Fellow, UC Denver
6/18/2008	Mary Kestler, MD	Delays in the Diagnosis of Tuberculosis	ID Fellow, UC Denver
9/3/2008	Michelle Haas, MD	HIV-1 Infection of FollicularCD4+ cells may be associated with increased BCl-2 levels and affect cell survival: Implications for persistent viral replication in lymphoid tissues	ID Fellow, University of Colorado Denver
10/1/2008	David Cohn, MD	TB Infection Control in Resource Limited Settings; Can it Be Done?	Professor of Medicine, Denver Health Hospital
10/15/2008	Douglas Fish, PharmD	Antimicrobial Pharmacodynamics: Assessing the role of Monte Carlo Simulation	Professor, School of Pharmacy
10/29/2008	Jerry Nick, MD	Neutrophil-induced enhancement of Pseudomonas aeruginosa biofilms	Assistant Professor, Division of Pulmonary Medicine, National Jewish Center
12/3/2008	Donald Gilden, MD		Professor, Department of Microbiology, UC Denver

2007

Date	Speaker	Topic	Affiliation/Contact
1/11/2007	Elizabeth Connick, M.D.	Primary HIV-1 Infection	UCD
1/18/2007	Edward Chan, M.D.	The skinny on Mycobacterium abscessus infection	UCD
2/1/2007	Thomas Campbell, M.D.	HHV-8 Infection and Kaposi’s Sarcoma	UCD
2/15/2007	Peter Palese	Influenza Virus Pandemics: Past and Future	Mount Sinai School of Medicine
2/22/2007	Ed Janoff, M.D.	Prevention of HIV-associated Bacterial Pneumonia	UCD
3/8/2007	Gary Doern, M.D.	Methicillin Resistant Staphylococcus aureus – The Coming Storm	University of Iowa
4/5/2007	Shannon Kasperbauer, M.D.	Pulmonary Mycobacterium Avium Complex	UCD
4/12/2007	Timothy Jenkins, M.D.	Evaluation and Classification of Staphylococcus aureus Bacteremia	UCD
4/19/2007	John Quinn, M.D.	Emerging Issues of Resistance in Gram-Negative Bacteria	Professor of Medicine, Rush University
4/26/2007	Sondra Crosby, M.D.	Caring for Refugee/Immigrant Women with HIV	Boston University Medical Center
5/3/2007	Joseph Morroni, M.D.	Biofilms: not just a sticky mess	UCD
5/10/2007	David Beckham, M.D.	Treatment of Viral Encephalitis	UCD
5/17/2007	Judith Currier, M.D.	Atherosclerosis and Metabolic Complications of HIV Infection	Tim Gill Lecture
5/31/2007	Kristin Brousseau, D.O.	Cognitive Impairment in the Aging HIV+ Patient	UCD
8/16/2007	Eoin Coakley, MD		Senior Medical Director, Clinical Research, The Royal College of Surgeons, Dublin, Ireland
9/6/2007	William Burman, MD	New TB Medications	Denver Health, UC Denver
9/13/2007	Priscilla Hsue, MD	HIV and Cardiac Disease	HCSF
9/27/2007	Mark Schaefer, ParmD	Personalized Medicine: Are We There Yet?	GSK, Group Director HIV
10/4/2007	Derrick Fine, MD	HIV and Kidney Disease	Johns Hopkins University
10/18/2007	Trish Perl, MD	Infection Control	Johns Hopkins University
11/1/2007	Bruce Mc Collister, MD	Antibiotic Tolerance	UC Denver
11/8/2007	Amiee Zaas, MD	Treating Invasive Fungal Infections in The Immunocompromised Patient	Duke University
11/15/2007	Lionel Mandell, MD	The New ATS/IDSA Guidelines for the Management of Community-Acquired Pneumonia	McMaster University
12/6/2007	Daniel Perlman, MD	Future Directions for MRSA Infections/New Diagnostic Tools and New Antimicrobials	Greater Denver Infectious Disease Specialists

2006

Date	Speaker	Title	Affiliation
1/5/2006	Randall Reeves, M.D.	The Skinny on TB: Anorexia, Debility, Nutrition or Phenotypic Risk Factors?	UCD/DHHA
1/12/2006	Stanley Louie, Ph.D.	Clinical Impact of Blockade Cellular Transporters in HIV Arena
2/2/2006	Marilyn Levi, M.D.	BK polyomavirus and transplantation	UCD
2/16/2006	Ches Thompson, M.D.	Epidemiology and Clinical Burden of Human Papillomavirus (HPV)	UCD
2/23/2006	Mary Ann DeGroote	MapQuest, the enduring hunt for M. paratuberculosis in Crohn's	UCD
3/2/2006	Herbert DuPont, M.D.	New Developments in Travelers' Diarrhea	University of Houston
3/9/2006	Scott Letendre, M.D	Management of Central Nervous System Complications of HIV Infection	HIV Neurobehavioral Research Center and Antiviral Research Center, UCSD
3/30/2006	Peter A Leone, MD	The North Carolina Acute HIV Program: Screening and Tracing the Transmission of HIV	UNC-Chapel Hill
4/6/2006	Lyle R. Petersen, M.D., M.P.H.	West Nile Virus in the Americas	Division of Vector-borne Infectious Diseases, Center for Disease Control and Prevention
4/13/2006	Robert Bonomo, M.D.	Antimicrobial Resistance and the Management of Serious Infections	Case Western Reserve School of Medicine
4/20/2006	Richard Martin, Ph.D	Asthma is an infectious disease.”	National Jewish Medical and Research Center
4/27/2006	Milene Saavedra, M.D.	Management of Patients with CF	UCD
5/4/2006	Wafaa El-Sadr, M.D., MPH	The MTCT-Plus Program: Lessons Learned and Practical Aspects of Antiretroviral Therapy in Resource-Poor Settings	Harlem Hospital and Columbia U
5/11/2006	Ellie Schoenbaum, MD	Menopause and Beyond: HIV in Older Women	Montefiore Medical Center/Albert Einstein College of Medicine
5/18/2006	Lisa Young, M.D.		UCD
6/1/2006	Amie Meditz, M.D.	Projects Exploring Why Women Have Lower HIV-1 Viral Loads Early in Disease	UCD
6/8/2006	David Beckham, M.D.	Mechanisms of Disease in Viral Encephalitis	UCD
6/22/2006	Myron Levin, M.D.	Herpes Zoster: Pathogenesis and Prevention	UCD
9/7/2006	Connie Price, M.D.	The Dying Prosthesis…and other Dilemmas in Orthopedic Device-Related Infections	UCD/DHHA
9/14/2006	Whitney High, M.D.	Tropical Medicine and Cutaneous Disease in the Returning Traveler	UCD
9/21/2006	Kieran Marr, M.D.	Fungal Infections in Immunocompromised Adults	University of Washington
10/5/2006	Mark Abzug, M.D.	The Enteroviruses: An Emerging Infectious Disease	UCD
10/19/2006	Peter Chin-Hong, M.D.	HPV in MSM	UCSF
10/26/2006	Michelle Roland, M.D.	Post-exposure Prophylaxis	UCSF
11/2/2006	Jeff Lennox, M.D.	Research Strategies to care for the Impossibly Difficult Patient	Emory University
11/16/2006	Andy Zolopa, M.D.	HIV Resistance and Clinical Implications	Stanford University
12/7/2006	Dale Gerding, M.D.	C. difficile	Loyola University

2005

Date	Speaker	Title	Affiliation
1/6/2005	Kathyrn Holmes, Ph.D.	SARS Update 2005	UCD
1/20/2005	Michael Wong, M.D.	Update in SOT in HIV+ Recipients	ID Beth Israel Deaconess/Harvard
1/27/2005	Sarah Parker, M.D.	Vaccines and autism: understanding the controversy	UCD
2/3/2005	Alicia Cronquist	Foodborne Disease Epidemiology	CDPHE
2/10/2005	Cara Wilson, M.D.	Update of the EP-1090 HIV-1 DNA Therapeutic Vaccine Trial	UCD
2/17/2005	Monica Carten, M.D.	HIV Post-Exposure Prophylaxis for nonoccupational exposures	UCD
3/3/2005	Susan Swindells, M.D.	Metabolic Complications of HIV Disease and Its Therapies	University of Nebraska
3/10/2005	Princy Kumar, M.D.	HIV as a Chronic Disease	Georgetown University
3/17/2005	Leland Shapiro, M.D.	Anthrax! Bacterial Pathogenesis and Novel Approach to Treatment	UCD
3/31/2005	Megan Clancy, M.D.	Clostridium difficile…Fact and Fiction	UCD
4/14/2005	Alison Elliott, M.D.	The impact of helminth infection in pregnancy on the response to immunisation and on disease incidence in infancy: preliminary results from a continuing intervention trial.	London School of Hygiene and Tropical Medicine
4/21/2005	Bob Belknap, M.D.	the Law & Order of TB Control in 2005	UCD
5/5/2005	Kathryn Robertson, M.D.	"Dendritic Cell Phenotype and Function in HIV-1-infected Patients"	UCD
5/12/2005	Ruth Berggren, MD	Sealing it up and rolling it out: HIV care in resource poor countries.”	Tulane University
5/19/2005	Mark Abzug, M.D.	Pneumococcal Vaccination and Immune Reconstitution in HIV-Infected Children	UCD
5/26/2005	Ed Gardner, M.D.	"Is Risk-Based HIV Testing Effective? New Data from Denver Health"	UCD
6/2/2005	Pam Skinner, PhD	In situ analysis of HIV and SIV specific CD8+ T cells	University of Minnesota
6/9/2005	Mark Cotton, M.B.	HIV in children from the Western Cape, South Africa – from bad to worse to better	Stellenbosch University
6/16/2005	William Burman, M.D.	"You can't always get what you want, but if you try sometimes... - a clinician's view of salvage antiretroviral therapy"	UCD
6/23/2005	Amie Meditz, M.D.	Sex Differences in Plasma HIV-1 Concentrations: A pilot study to investigate HIV-1 Replication and CCR5 Expression in Lymphoid Tissue of Women compared to Men	UCD
9/2/2005	Gary Dubin, M.D.	HPV Vaccine	GSK
9/8/2005	Kees Rietmeijer, M.D.	Lymphogranuloma venerum among Men Who Have Sex With Men	Denver Public Health
9/22/2005	Maggie Wierman, M.D.	Metabolic Bone Disease in HIV patients	UCD/Denver VAMC
9/29/2005	Adriana Weinberg, M.D.	Cytomegalovirus Infection in the Era of HAART: Better Immunity and Fewer Reactivations	UCD
10/20/2005	Stanley Derezinski, M.D.	Minimizing Antibiotic Resistance: The Fluoroquinolones.	Stanford
10/27/2005	Peter Pappas, M.D.	Immunotherapy for Invasive Fungal Infections: Is There a Role in Clinical Care?	Univ of AL
11/3/2005	Mary Bessesen, M.D.	Nosocomial Aspergillosis	UCD
11/17/2005	Greg Everson, M.D.	Antiviral Therapy of Advanced Hepatitis C: Pros and Cons	UCD

2004

Date	Speaker	Title	Affiliation
1/8/2004	Philip Keiser, M.D.	Utility of Cohort Comparisons of Anti-retroviral Regimens	UT Southwestern
1/15/2004	Jack Stapleton, M.D.	GB Virus: A Major Factor in HIV Long Term Nonprogression	Univ of Iowa
1/29/2004	Kevin High, M.D.	Infection and Immunity in Older Adults	Wake Forest University
2/5/2004	Norbert Voelkel	Expression of HHV-8 in Primary Pulmonary Hypertension	UCD
2/19/2004	Kathryn Lee, M.D.	Resistant CMV in BMT Recipients	UCD
3/4/2004	Marin Kollef, M.D.	Optimization of the antibiotic therapy for hospital-asasociated pneumonia	Washington University
3/18/2004	Megan Clancy, M.D.	Community and Hospital Acquired MRSA Infections at Denver Health	UCD
4/1/2004	Henry F. Chambers, M.D.	Community MRSA	UCSF
4/8/2004	Todd Kingdom, M.D.	Current Concepts on the Pathophysiology of Chronic Rhinosinusitis	UCD
4/15/2004	Ken Thomson, Ph.D.	Academic Perspectives in Emerging Issues of Resistance in Gram-Negative Bacteria	University of Nebraska
4/22/2004	Susan Cu Uvin, MD	Gynecological Care: Concerns of HIV-Infected Women	Brown University
4/29/2004	Bill Burman, M.D.	Invasive nocardiosis - Can we ever move beyond anecdotes in the treatment of unusual, but severe infectious diseases?	UCD
5/20/2004	David Wyles, M.D.	HCV/HIV Co-infection Update and Beyond: In Vitro Activity and resistance to a HCV Serine Protease Inhibitor	UCD
5/27/2004	Andrew Pavia, M.D.	Women, pregnancy and HIV: What have we learned in the last 10 years.	University of Utah
6/3/2004	John Koeppe, M.D.	HIV-1 specific T cell Responses in Viral Evolution – A Major Cause of Disease Progression?	UCD
6/10/2004	Ed Gardner, M.D.	Adherence to Antiretrovirals in the Denver Health System	UCD
6/17/2004	Bruce Walker, M.D.		Harvard University
6/24/2004	Robert Belknap, M.D.	Tuberculosis Elimination: the Colorado Perspective	UCD
9/9/2004	Michael Miller, Ph.D.	Resistance, Replication Capacity and Intracellular Pharmacology of NRTIs	Gilead
9/16/2004	Arturo Casadeval, M.D., Ph.D	'New insights into cryptococcal pathogenesis and development of antibody therapy'	Albert Einstein College of Medicine
9/23/2004	J.J. Hakim, M.D.	Impact of HIV Epidemic on Clinical Practice in Zimbabwe	Tim McGill Annual Lecture
10/7/2004	Connie Price, M.D.	Science and Superstitions in Infection Control	UCD
10/14/2004	Jo-Anne van Burik, M.D.	Antifungal prophylaxis: Clinical updates	Univ of Minnesota
10/21/2004	Elizabeth Connick, M.D.	Why Have Efforts To Augment HIV-Specific Immunity Failed to Result in Virologic Control? New Insights From Lymphoid Tissue Studies	UCD
10/28/2004	Michelle Barron, M.D.	Influenza in the 21st Century	UCD
11/4/2004	Michael Saubolle, Ph.D.	Interesting Case Presentations from the Southwest Deserts	University of Arizona
11/11/2004	Mike Pfaller, M.D.	Has Antifungal Testing Come of Age?	University of Iowa
11/18/2004	John Perfect, M.D.	Advancing the Art of Antifungal Therapy: New Therapeutic Options and Strategies	Duke University
12/2/2004	Chris Petropoulos, Ph.D.	A Closer Look at HIV-1 Co-Receptor Tropism in the Emerging Era of Entry Inhibitors	Virologic Labs
12/9/2004	Alan T. Evangelista, Ph.D.	Antimicrobial Resistance Trends and Appropriate use of Antibiotics	Ortho-McNeil Pharmaceuticals

2003

Date	Speaker	Title	Affiliation
1/9/2003	Thomas Patterson	New Antifungal Agents: New Choices	UTHSC-SA
1/16/2003	Dennis Maki	The Need for a New Paradigm for Control of Nosocomial Infection in the ICU	Univ of Wisconsin
1/23/2003	Frank Judson	Bioterrorism: A Holistic Approach to Assessing Risk and Planning for Control	UCD
1/30/2003	Steven Johnson	West Nile Virus	UCD
2/6/2003	Ed Abraham	New Treatments for Sepsis	UCD
2/20/2003	Judith Andersen	History of the Plague	UCD
2/27/2003	Nalini Rao	An Update on the Diagnosis and Management of Osteomyelitis	University of Pittsburgh
3/6/2003	Donna Sweet	HIV care: A Perspective on Women	University of Kansas
3/13/2003	Dan Kuritzkes	HIV Drug Resistance: Strategic Implications for Therapy	Harvard University
4/3/2003	Veronica Miller	Definition of Treatment Failure	George Washington University
4/10/2003	Ferric Fang	Can We Treat Infectious Diseases by Modulating Host Defenses?	University of Washington
4/17/2003	Joseph Falkinham	Epidemiology and Ecology of Mycobacterium avium	Virginia Polytechnic University
4/24/2003	Kathleen Squires	Clinical Care Update: Antiretroviral Therapies for Women	USC
5/1/2003	John Koeppe	Mechanism of CD4+ T cell escape	UCD
5/8/2003	Bill Burman	Why isn't TB going away in Denver? Insights from conventional and molecular epidemiology	UCD
5/15/2003	James Neid	KSHV infection of pulmonary endothelial cells: clinical and laboratory significance	UCD
5/22/2003	Mary Hamel	The Effect of Daily Cotrimoxazole for the Prevention of HIV-Related Opportunistic Infections on the Development of Resistance in Common Pathogens in Africa	CDC
5/29/2003	David Wyles	“Toward an in vitro system to characterize novel anti-HCV compounds	UCD
6/5/2003	Mark Thrun	HIV Prevention: Moving Beyond Condoms	UCD
6/12/2003	Bruce McCollister	Interferon-gamma in host defense against S. typhimurium	UCD
6/19/2003	Kathryn Lee	CMV-Specific Immune Reconstitution in BMT Patients	UCD
6/26/2003	Charles Dinarello	"Specific anti-cytokine therapies work but at the expense of decreased host defense against infection."	UCD
9/4/2003	Richard Ogden, Ph.D.	HIV Resistance, Fitness, and Pathogenicity: Current Data and Ongoing Research	Agouron
9/11/2003	Mike Iseman, M.D.	Primum Non Nocere and RIF-PZA Treatment of Latent TB: Mutually Exclusive?"	UCD
9/25/2003	Mark Sulkowski, M.D.	HCV in the HIV-infected Patient	Johns Hopkins
10/2/2003	Mahmoud A. Ghannoum, M.Sc., Ph.D.	Candida Biofilms and the Role of Antifungals	Case Western
10/16/2003	David Simpson, M.D.	Neurological Complications of HIV	Mt. Sinai
10/23/2003	S. Ferrando, M.D.	Case Studies in HIV	Cornell University
10/30/2003	Dimitrios Kontiannis, M.D.	Evolving Epidemiology of Fungal Infections with a Special Focus on Candidemia	MD Anderson
11/6/2003	Ken Lichtenstein, M.D.	Antiretroviral Toxicities, An Alternative View	Rose Medical Center
11/13/2003	Max Salfinger, M.D.	HIV/TB Co-Infection Up-Date	NY State Dept of Health
11/20/2003	Nelson Gantz, M.D.	Chronic Fatigue Syndrome: Real or Imaginary	UCD/Boulder
12/4/2003	Ken Tyler, M.D.	West Nile Virus	UCD
12/11/2003	Marty St. Clair	Nucleoside Therapy in 2003; What Have We Learned and Where do we go From Here?	GSK

Directory: academics -> colleges -> medicalschool -> departments -> medicine
medicalschool -> Gail Armstrong, dnp, PhD(c), acns-bc, cne
colleges -> Course Number: Course Title: Semester Credit Hours
colleges -> Assessment Report Spring 2011
colleges -> Susan muaddi darraj 3530 Sweet Air Road 410-258-0688
colleges -> Brenda J. Allen University of Colorado Denver
colleges -> Educational background
medicine -> Curriculum vitae name

Download 277.87 Kb.

Share with your friends: